Filings

6 documents · 7 matches

1. DMAA Drugs Made In America Acquisition Corp. 10-Q 2026-08-14

   Item 4. Controls and Procedures.

   material weakness of inadequate segregation of duties within account processes due to limited personnel, insufficient written policies and procedures for accounting
   1 match in this document Show context Copy citation

2. DMAA Drugs Made In America Acquisition Corp. 10-Q 2026-05-14

   Item 4. Controls and Procedures.

   material weakness of inadequate segregation of duties within account processes due to limited personnel, insufficient written policies and procedures for accounting
   1 match in this document Show context Copy citation

3. DMAA Drugs Made In America Acquisition Corp. 10-K 2026-04-15

   Item 9A. Controls and Procedures.

   material weakness of inadequate segregation of duties within account processes due to limited personnel, insufficient written policies and procedures for accounting
   2 matches in this document Show context Copy citation

4. DMAA Drugs Made In America Acquisition Corp. 10-Q 2025-11-18

   Item 4. Controls and Procedures.

   material weaknesses of inadequate segregation of duties within account processes due to limited personnel and insufficient written policies and procedures
   1 match in this document Show context Copy citation

5. DMAA Drugs Made In America Acquisition Corp. 10-Q 2025-08-14

   Item 4. Controls and Procedures.

   material weakness of inadequate segregation of duties within account processes due to limited personnel and insufficient written policies and procedures
   1 match in this document Show context Copy citation

6. DMAA Drugs Made In America Acquisition Corp. 10-Q 2025-05-20

   Item 4. Controls and Procedures.

   material weakness of inadequate segregation of duties within account processes due to limited personnel and insufficient written policies and procedures
   1 match in this document Show context Copy citation